The common markers of CSCs are CD34+CD38− for AML, and CD133+, CD44+, and others for solid tumors, as these cells display higher abilities of tumor ignition in nude and NOD/SCID mice [37]. The gene discussed is CD34; the disease is acute myeloid leukemia.